17th Jan 2005 10:30
AstraZeneca PLC17 January 2005 DEALING BY DIRECTORS COMPANIES ACT 1985 SECTION 324/329 WE HEREBY INFORM YOU THAT, ON 14 JANUARY 2005, DR H L MOGREN, A DIRECTOR OF THECOMPANY, CEASED TO HAVE AN INTEREST IN AN OPTION OVER 6,462 ASTRAZENECA PLCORDINARY SHARES OF USD0.25 EACH FOLLOWING ITS EXPIRY. THE OPTION WAS ORIGINALLY GRANTED TO DR MOGREN IN 1998 FOR A PERIOD OF SEVENYEARS OVER SHARES IN ASTRA AB UNDER THE ASTRA SHAREHOLDER VALUE INCENTIVE PLAN.THE OPTION WAS SUBSEQUENTLY CONVERTED INTO AN OPTION OVER ORDINARY SHARES INASTRAZENECA PLC IN APRIL 1999. THE OPTION HAS NOT BEEN EXERCISED BY DR MOGRENAND HAS CONSEQUENTLY EXPIRED ON REACHING THE SEVENTH ANNIVERSARY OF THE DATE OFGRANT. DETAILS OF THE OPTION ARE AS FOLLOWS:- NUMBER OF ASTRAZENECA SHARES OVER EFFECTIVE OPTION PRICE PER MARKET PRICE OF ASTRAZENECA SHARES WHENWHICH OPTION WAS HELD SHARE OPTION EXPIRED 6,462 410.53SEK 245.00SEK FOLLOWING THE EXPIRY OF THIS OPTION, DR MOGREN HOLDS OPTIONS OVER 254,722ORDINARY SHARES OF ASTRAZENECA PLC. G H R MUSKER COMPANY SECRETARY 17 JANUARY 2005 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Astrazeneca